Paper59517
The effect of different oral anticoagulants on diphenylhydantoin (DPH) and tolbutamide metabolism.
Skovsted L and 3 others. Acta Med Scand, 1976. Cited by 19 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The effect of different oral anticoagulants on diphenylhydantoin (DPH) and tolbutamide metabolism. Papers, record 59517. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/59517
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The effect of different oral anticoagulants on diphenylhydantoin (DPH) and tolbutamide metabolism.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Coumarins | Major topic |
| Dicumarol | Major topic |
| Phenindione | Major topic |
| Phenprocoumon | Major topic |
| Phenytoin | Major topic |
| Tolbutamide | Major topic |
| Warfarin | Major topic |
| Half-Life | |
| Humans |
Source PubMed
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 9,880,092 | Treatment of concomitant illnesses in patients receiving anticonvulsants: drug interactions of clinical significance. | Drug Saf | 1998 | https://conductscience.org/library/papers/9880092 | PubMed |
| 9,663,807 | Cytochrome P4502C9: an enzyme of major importance in human drug metabolism. | Br J Clin Pharmacol | 1998 | https://conductscience.org/library/papers/9663807 | PubMed |
| 8,792,056 | Clinically important drug interactions with anticoagulants. An update. | Clin Pharmacokinet | 1996 | https://conductscience.org/library/papers/8792056 | PubMed |
| 8,424,795 | Site-directed mutation studies of human liver cytochrome P-450 isoenzymes in the CYP2C subfamily. | Biochem J | 1993 | https://conductscience.org/library/papers/8424795 | PubMed |
| 7,042,173 | Pharmacokinetic interactions with antiepileptic drugs. | Clin Pharmacokinet | 1982 | https://conductscience.org/library/papers/7042173 | PubMed |
| 7,030,708 | Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2. | Drugs | 1981 | https://conductscience.org/library/papers/7030708 | PubMed |
| 7,009,138 | Drug interactions with phenytoin. | Drugs | 1981 | https://conductscience.org/library/papers/7009138 | PubMed |
| 2,180,613 | Pharmacokinetic drug interactions with phenytoin (Part II). | Clin Pharmacokinet | 1990 | https://conductscience.org/library/papers/2180613 | PubMed |
| 1,493,081 | Co-regulation of phenytoin and tolbutamide metabolism in humans. | Br J Clin Pharmacol | 1992 | https://conductscience.org/library/papers/1493081 | PubMed |
| 797,504 | Drug interactions and clinical pharmacokinetics. | Clin Pharmacokinet | 1976 | https://conductscience.org/library/papers/797504 | PubMed |
| 401,727 | Drug interactions with oral sulphonylurea hypoglycaemic drugs. | Drugs | 1977 | https://conductscience.org/library/papers/401727 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/59517
GET https://conductscience.org/api/papers/v1/59517/authors